FDA Grants De Novo to ML-based, Real-time Indicator of Patient Deterioration

 In News

Source: Fifth Eye Inc.

Fifth Eye’s noninvasive tool is the first to provide continuous monitoring of hemodynamic status using a single ECG lead

Read the full press release >